📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PI3Kd inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax. (2020)

First Author: Serrat N

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020001584

PubMed Identifier: 32898249

Publication URI: http://europepmc.org/abstract/MED/32898249

Type: Journal Article/Review

Volume: 4

Parent Publication: Blood advances

Issue: 17

ISSN: 2473-9529